Statement of Principles concerning sinusitis (Reasonable Hypothesis) (No. 73 of 2018)

The instrument revolves around several interlocking concepts: the definition of sinusitis, the reasonable hypothesis evidentiary step, a prescribed list of contributory or aggravating factors, timing and service‑relationship requirements, and defined medical and exposure terms in the Schedule.

Definition of sinusitis and death from sinusitis. Section 7(2) defines sinusitis as inflammation of the nasal cavity and paranasal sinuses, and explicitly includes both acute and chronic sinusitis. A non‑exhaustive clinical picture is noted in the instrument’s note: nasal blockage/congestion, nasal discharge (anterior or postnasal drip), facial pain/pressure, reduced or lost smell, and fluid in the sinuses. Section 7(5) extends the concept to death from sinusitis, by including death from a terminal event or condition that was contributed to by the person’s sinusitis. The Schedule defines “terminal event” to include pneumonia, respiratory failure, cardiac arrest, circulatory failure and cessation of brain function.

Reasonable hypothesis and factors. Section 9 sets out the key legal mechanism: “At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting sinusitis or death from sinusitis with the circumstances of a person's relevant service.” The list is prescriptive and separated for clinical onset and for clinical worsening of sinusitis. Many factors are mirrored for onset and worsening (for example, impaired drainage, infection, immunocompromised state, specified medical condition, therapeutic radiation, smoking, exposure to second‑hand smoke, inhalation of drugs/irritants, inhalation of airborne dusts/smoke/fumes/vapours, specified dental condition when maxillary sinus only). Additional factors for worsening include use of specified non‑selective NSAIDs for sinusitis with nasal polyps (s 9(21)) and inability to obtain appropriate clinical management for sinusitis (s 9(22)).

Timing, thresholds and quantification. Several factors include explicit temporal or quantitative thresholds. Smoking must reach at least one pack‑year and begin at least one year prior to clinical onset/worsening; if smoking has ceased, onset/worsening must occur within three months of cessation (s 9(6) and s 9(16)). Second‑hand smoke exposure requires at least 1,000 hours before onset/worsening, with the first exposure at least one year before clinical onset/worsening and last exposure within three months before onset/worsening (s 9(7) and s 9(17)). Inhalation of drugs or irritant substances requires acute nasal symptoms within 48 hours of inhalation and scarring or erosion of mucosa (s 9(8) and s 9(18)). Inhalation of airborne dusts, smoke from fires, or fumes/vapours from fuel or chemical agents is prospectively limited to within 48 hours before clinical onset/worsening (s 9(9) and s 9(19)). These thresholds are further operationalised in the Schedule, for example defining the pack‑year calculation (Schedule).

Relationship to service and scope limits. Section 10(1) requires that any factor in s 9 be related to the relevant service rendered by the person. Section 10(2) creates a specific application limit: subsections 9(11) to 9(22) (the factors relating to clinical worsening and later additional factors) apply only to “material contribution to, or aggravation of, sinusitis where the person's sinusitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.” That allocates the worsening/aggravation factors to scenarios where sinusitis pre‑existed and was not caused by service but may have been materially contributed to or aggravated by service.

Definitions and cross‑reference. The Schedule is integral: it contains definitions that materially alter how the listed factors operate. Examples: “impaired drainage of the sinus” lists anatomical deformities, soft tissue abnormalities and foreign bodies; “immunocompromised state as specified” lists treatment with immunosuppressive drugs, malignant disease, chronic renal failure, HIV infection, severe malnutrition and various transplants; “specified dental condition” and “specified medical condition” are enumerated; “being exposed to second‑hand smoke” is defined as inhaling smoke in an enclosed space; “pack‑year” is defined by an explicit calculation. Section 11 provides a mechanism for interaction with other SoPs: where a factor refers to an injury or disease that has its own SoP, the other SoP applies in accordance with its own terms.

Practical consequence: the SoP translates clinical facts into legal triggers. For claimants, a documented presence of any one enumerated factor, with the timing and quantification set out, and a link to relevant service, can be used to establish a reasonable hypothesis of service connection. For decision‑makers, the SoP functions as the list of acceptable medical‑causal anchors to be checked against the claim’s evidence.

The instrument is directed at, and practically affects, several categories of persons and organisations engaged in the veterans’ compensation system. The primary class affected comprises current and former members of the Australian Defence Force and related categories defined as “relevant service” in the Schedule: operational service, peacekeeping service, hazardous service, British nuclear test defence service, and under MRCA, warlike and non‑warlike service (Schedule definition of “relevant service”). The instrument therefore applies to veterans, members of Peacekeeping Forces and members of the Forces whose claims fall under s 120A VEA or s 338 MRCA (s 5).

Claimants and their representatives. Individual claimants seeking entitlements for sinusitis or death from sinusitis are directly affected because the SoP sets out the medical factors that the Repatriation Medical Authority considers sufficient to raise a reasonable hypothesis that the condition is related to service (s 9). Claimants must marshal evidence to satisfy the listed factors and the timing/relationship requirements in s 10. Where the factor references another disease covered by a separate SoP, the claimant must be prepared to rely on the terms of that other SoP (s 11).

Decision‑makers within the Department and statutory bodies. Administrative decision‑makers who determine entitlement claims under the VEA and MRCA must apply the SoP when assessing whether a reasonable hypothesis has been raised. The instrument is made under s 196B(2) VEA, indicating the Repatriation Medical Authority’s role in formulating medical principles for use by decision‑makers (s 3). Although the instrument does not itself specify the adjudicative process, it prescribes the medical building blocks used by the decision‑maker to determine causal connection.

Medical practitioners and treating clinicians. The SoP shapes the kind of clinical documentation and opinion that will be relevant. Clinicians preparing reports for claimants or for the Department need to address the specific factors and timing set out in s 9 and the Schedule. Examples include documenting impaired sinus drainage (Schedule definition), quantifying smoking history in pack‑years (Schedule), documenting second‑hand smoke exposure hours, recording inhalation incidents within 48 hours prior to onset/worsening, and describing scarring/erosion of mucosa where relevant.

Families and estates. For deaths where sinusitis contributed to a terminal event (s 7(5)), the decedent’s family or estate is affected because the SoP governs the medical linkage criteria relevant to death‑based claims. The Schedule’s list of terminal events (pneumonia, respiratory failure, cardiac arrest, circulatory failure, cessation of brain function) clarifies which proximate causes may be linked to underlying sinusitis for SoP purposes.

Legal advisers, advocates and reviewers. Lawyers, advocates and administrative reviewers who advise on or review decisions under the VEA and MRCA must apply the SoP’s factors and definitions. The instrument’s cross‑reference to other SoPs (s 11) requires them to consider the state of any relevant SoP when a listed factor references another injury or disease.

The Repatriation Medical Authority itself, and entities that produce ICD‑10‑AM codes. The SoP references ICD‑10‑AM codes (s 7(3)-(4)), tying the definition of sinusitis to standard diagnostic coding while specifying that the SoP’s meaning is given by s 7(2). The Authority’s role in framing and updating SoPs means this instrument affects ongoing medical policy and administrative practice.

In short, the SoP alters evidence expectations across the claimant/decision‑maker/clinician ecosystem. It allocates the burden of producing timing‑specific and quantifiable medical evidence to establish any one of the listed factors, and it requires that those factors be related to the person’s relevant service (s 10(1)). The listed temporal thresholds and definitions in the Schedule determine which exposures and conditions will be treated as legally significant for the purposes of raising a reasonable hypothesis.

The Statement of Principles is an evidentiary instrument rather than a statute that imposes direct duties or confers rights in isolation. Nevertheless it creates operational duties for decision‑makers and practical obligations for claimants, clinicians and advisers within the veterans’ entitlements framework.

Duty on decision‑makers to apply the SoP. The instrument is made under s 196B(2) VEA (s 3) and is intended to be used in determining whether a reasonable hypothesis exists connecting sinusitis or death from sinusitis with relevant service. Decision‑makers processing claims under s 120A VEA or s 338 MRCA (s 5) have the practical duty to consider the SoP’s factors and Schedule definitions when assessing medical causation. The SoP sets out whether particular clinical or exposure facts are sufficient to raise a reasonable hypothesis; the decision‑maker’s duty is to examine the evidence against those criteria.

Duty to relate factors to relevant service. Section 10(1) imposes a specific legal requirement: any factor from s 9 relied on to raise a reasonable hypothesis must be related to the person’s relevant service. That is, factual proof must demonstrate a nexus between the listed factor and the period or circumstances of relevant service. The SoP does not define the full legal test for causation; it identifies the medical triggers that will meet the reasonable hypothesis threshold when connected to relevant service.

Application limitation for aggravation. Section 10(2) constrains the application of subsections 9(11)-9(22) to cases of material contribution or aggravation where sinusitis was suffered or contracted before or during, but did not arise out of, relevant service. Decision‑makers must therefore evaluate whether the sinusitis pre‑existed the service and whether service materially contributed to or aggravated the condition, applying the listed factors only in that context.

Claimant’s evidentiary obligations. Practically, claimants have the duty to produce or arrange for medical and other evidence that establishes the presence of at least one factor in s 9, with the required timing and quantitative detail. Examples of necessary evidence include clinical records documenting impaired sinus drainage (Schedule), smoking history quantified in pack‑years (Schedule), records showing hours of second‑hand smoke exposure (Schedule definition of “being exposed to second‑hand smoke” and s 9(7)/(17)), documentation of inhalation events within 48 hours of onset/worsening, dental records for maxillary sinus cases (s 9(10)/(20) and Schedule), and records of therapeutic radiation fields (s 9(5)/(15)).

Use of other SoPs. Section 11 creates a procedural duty: where a factor refers to an injury or disease that has its own SoP under s 196B(2) VEA, that other SoP must be applied “in accordance with the terms of that Statement of Principles as in force from time to time.” Practitioners must therefore identify any interlinked SoPs and apply them as currently framed.

Rights as to reasonable hypothesis. A claimant has a practical right that, if proof of any one of the s 9 factors (properly related to service) is established, a “reasonable hypothesis” of service connection is raised for administrative purposes. That does not guarantee an entitlement, but it triggers further steps in the statutory claims process; the SoP operationalises the point at which medical causation for administrative purposes is considered made.

No criminal or civil penalties in the instrument. The SoP itself does not create offences, fines or penalties. Enforcement is administrative: it changes how medical linkage is evaluated within the VEA/MRCA claims regime; any consequences (acceptance or rejection of claims, entitlement awards) flow from the underlying Acts and administrative decision‑making processes, not from the SoP as an instrument of penalty.

Definitions as operative obligations. The Schedule contains operational definitions that act as obligations to demonstrate specific factual elements. For example, pack‑year is a precise calculation (Schedule), “being exposed to second‑hand smoke” requires enclosed‑space inhalation, and “immunocompromised state as specified” lists specific conditions and treatments. Practitioners must address these definitional criteria when assembling evidence.

In summary, the SoP imposes duties on decision‑makers to apply the enumerated medical factors and the Schedule definitions when assessing reasonable hypothesis in sinusitis claims, and places practical evidence‑gathering obligations on claimants and clinicians to establish those factors and their relationship to relevant service.

The Statement of Principles is not a penal instrument and contains no criminal sanctions, fines, or administrative penalties within its text. Its enforcement is administrative, functioning as a binding guidance tool for the medical causation step in claims management under the VEA and MRCA.

Administrative effect in claims determination. The SoP’s practical effect is to structure the medical proof required to raise a reasonable hypothesis that sinusitis or death from sinusitis is connected to relevant service (s 9). Decision‑makers use the SoP to determine whether further entitlements or liabilities under the VEA/MRCA process should be engaged. The outcome of applying the SoP therefore influences administrative determinations such as acceptance or rejection of claims, the need for further medical examination or specialist opinion, and the entitlement to treatment or compensation provided by the underlying legislation. Any adverse outcome for a claimant resulting from application of the SoP therefore arises through the statutory claims process rather than through penalties embedded in the SoP.

No criminal enforcement powers. The instrument does not confer investigation, prosecution or sanctioning powers to the Repatriation Medical Authority or to other bodies beyond what already exists under the VEA/MRCA. The Authority’s role in making SoPs is statutory (s 3), but the instrument itself is medical‑scientific guidance and not a law of offence.

Administrative review and appeal pathways lie outside the instrument. While the SoP informs the medical causation assessment that feeds into administrative decisions under the VEA/MRCA, the text does not set out the review or appeal mechanisms. Those pathways , such as internal review, Veterans’ review bodies or judicial review , are established in the VEA/MRCA and related administrative law, not in this SoP. Any enforcement in the sense of challenge to a decision applying the SoP therefore occurs under those separate statutory processes.

Implementation and discretionary application. Enforcement is subject to administrative discretion and medical interpretation. Decision‑makers must determine whether evidence satisfies the listed factors in s 9 and whether those factors are related to relevant service per s 10(1). The SoP prescribes definitional thresholds (for example, pack‑year calculations; 1,000 hours of second‑hand smoke exposure; 48‑hour windows for inhalation factors) contained in s 9 and the Schedule. Interpretation disputes over whether evidence meets those thresholds will influence administrative outcomes and, where contested, can give rise to internal review or merits/ judicial review applications.

Potential for evidentiary disputes. Because the SoP sets specific quantitative and temporal criteria, disputes can arise where evidence is incomplete, ambiguous or contested , for example, proof of 1,000 hours of second‑hand smoke exposure in an enclosed space, or the timing of a smoking cessation relative to a three‑month window. The SoP itself does not prescribe how to resolve such evidentiary disputes beyond setting the criteria; resolution occurs within the decision‑maker’s factual assessment and potentially through the statutory review mechanisms provided by the VEA/MRCA.

Interaction with other SoPs. Section 11 mandates that where a listed factor refers to another injury or disease covered by a different SoP, that other SoP applies. This creates an enforcement‑by‑reference mechanism where medical linkage may require applying multiple SoPs according to their own terms as in force.

Record‑keeping and clinical documentation as compliance levers. Because the SoP relies on clinical and exposure evidence, the practical enforcement mechanism will often be records review. The quality and specificity of clinical notes, service records, exposure logs and dental/oncology documentation will determine whether an administrative decision finds that a reasonable hypothesis is raised.

In short, this instrument’s enforcement is through its binding use in the administrative claims process under the VEA and MRCA. It governs factual thresholds for medical linkage, but does not itself impose sanctions; consequences for claimants depend on how decision‑makers apply the SoP against submitted evidence and on any subsequent reviews or appeals under the parent Acts.

The Statement of Principles is made under a specific provision of the Veterans’ Entitlements Act 1986 and operates within the statutory framework of veterans’ entitlements and military compensation. Its interconnections are textual and procedural rather than extraneous to the VEA/MRCA system.

Statutory genesis and application. The instrument is made under subsection 196B(2) of the VEA (s 3). Its stated application is to claims to which s 120A of the VEA or s 338 of the MRCA apply (s 5). Those cross‑references locate the SoP within the adjudicative machinery of those Acts: the SoP is medical evidence guidance used to determine, for administrative purposes, whether a reasonable hypothesis exists linking an injury/disease to relevant service. The instrument does not alter the statutory text of the VEA or MRCA; it supplements adjudication under those Acts with medical principles determined by the Repatriation Medical Authority.

Interaction with other Statements of Principles. Section 11 establishes a direct interaction rule: where a factor in this SoP refers to an injury or disease for which another SoP exists under s 196B(2) VEA, the other SoP applies “in accordance with the terms of that Statement of Principles as in force from time to time.” Practically, that means medical factors that depend on or overlap with other disease states trigger the other SoP’s definitions and criteria rather than those in this instrument. For instance, if a listed factor refers to a respiratory tract infection or an immunocompromised state that is covered in more detail by a separate SoP, the decision‑maker must consult and apply that other SoP’s terms.

ICD‑10‑AM referencing. Section 7(3)-(4) notes that while sinusitis attracts ICD‑10‑AM codes J01 or J32, “in applying this Statement of Principles the meaning of sinusitis is that given in subsection (2).” The instrument therefore uses the ICD‑10‑AM only as an ancillary classification reference; the operative definition for legal purposes is the textual definition in s 7(2). The ICD reference links the SoP to standard diagnostic coding used in health systems but does not supplant the SoP’s functional definition.

Relationship with medical standards and practice. The SoP expressly states the Repatriation Medical Authority’s view that there is “sound medical‑scientific evidence” that sinusitis and death from sinusitis can be related to relevant service (s 8). That statement situates the SoP as a medical policy instrument grounded in the Authority’s scientific assessment. It therefore interfaces with clinical practice and medical reporting: clinicians’ opinions used in claims are to be measured against the factors and definitions contained in the SoP.

Administrative law and review. Although the SoP itself does not set out appeal routes, it will be used within decisions that are reviewable under the VEA/MRCA processes and broader administrative law (judicial review, merits review bodies). Disputes about interpretation or application of the SoP will therefore engage the remedial architecture established by those statutes and administrative law principles. The SoP’s text does not alter those statutory review rights; it is one element in the evidence considered in administrative adjudication.

No express interaction with other Commonwealth statutes. The instrument does not reference other Commonwealth legislation outside the VEA and MRCA. Its primary legal interactions are therefore internal: with the VEA, MRCA, other SoPs under s 196B(2) VEA, and medical coding systems (ICD‑10‑AM).

Operational coordination with clinical coding and service records. The SoP’s reference to ICD‑10‑AM and the detailed Schedule definitions creates practical interaction points with health records, service logs and dental/oncology records. Decision‑makers will need to reconcile the SoP’s specified criteria with clinical documentation, service exposure records and any other statutory evidentiary requirements.

In summary, the SoP operates as an authoritative medical‑scientific guideline within the VEA/MRCA administrative framework. It interacts with other SoPs by explicit cross‑reference (s 11), links to diagnostic coding for administrative clarity (s 7(3)-(4)), and functions within the reviewable legal processes established by the underlying Acts.

The instrument contains its own immediate amendment record limited to a single repeal and the dates of making and commencement. It is designated No. 73 of 2018, dated 24 August 2018, and it commences on 24 September 2018 (s 2). Section 4 expressly repeals the prior Statement of Principles concerning sinusitis No. 9 of 2010 (Federal Register of Legislation No. F2010L00553) that had been made under subsection 196B(2) of the VEA. The repeal is complete: the 2010 instrument is replaced by this 2018 SoP.

Formal legal basis. The instrument is made under subsection 196B(2) of the VEA (s 3), which is the statutory mechanism by which the Repatriation Medical Authority determines Statements of Principles. The text therefore confirms continuity of the Authority’s statutory function to update and promulgate SoPs, with the 2018 instrument being the current statement in force from its commencement date.

No subsequent amendments or revocations are recorded within the supplied text. The instrument’s s 11 contemplates that other Statements of Principles may be “in force from time to time,” implying ongoing updates to the SoP framework generally; however, the supplied document contains no later amendment schedule, ministerial variation, or update beyond the 2018 replacement of the 2010 SoP.

Practical implications of repeal. The repeal in s 4 means that any claims assessed after the 24 September 2018 commencement date should be evaluated against this SoP rather than the 2010 SoP. Where claim‑relevant events or medical opinions were formulated under the 2010 SoP, practitioners must check whether evidence remains adequate against the 2018 thresholds and definitions, particularly where the Schedule contains explicit operational calculations or changed enumerations (for example, the Schedule’s pack‑year calculation and list of specified medical/dental conditions). The instrument does not state transitional provisions; the repeal appears to be a straight replacement effective on commencement.

Record on the Federal Register and signature. The instrument records that the Common Seal of the Repatriation Medical Authority was affixed and names Professor Nicholas Saunders AO as Chairperson. It lists its publication metadata, and the instrument’s name and identification number are provided in the opening. That formal record signals the instrument’s placement on the Federal Register of Legislation and its administrative formalities.

No retrospective amendment or savings clause is included in the text. There is no explicit saving of decisions made under the prior 2010 SoP or transitional evidence procedures; the instrument simply repeals the earlier SoP and comes into force on the commencement date indicated. Practitioners should therefore verify whether decisions or proceedings that straddle the repeal date require an assessment of which SoP applies, bearing in mind the instrument’s commencement provision (s 2) and the underlying statutes’ procedural rules concerning claims lodged or decisions made before or after that date.

In sum, the amendment history provided within the instrument itself is limited: it replaces the 2010 sinusitis SoP with the 2018 version; no further amendments are documented in the supplied text.

The instrument text does not record any litigation history. It is a Statement of Principles determined by the Repatriation Medical Authority under s 196B(2) VEA and does not itself summarise or reference judicial decisions, case law, or administrative review outcomes that have interpreted or challenged this specific SoP. The document contains no references to past tribunal or court decisions, nor does it assert that the SoP has been considered in litigation.

Practical consequences of the absence of litigation record. Because the instrument does not provide a litigation history, practitioners must not assume precedent about interpretative points from this text alone. Any contested questions about how to apply the SoP’s factors, how to prove the quantifiable thresholds (for example, 1,000 hours of second‑hand smoke exposure, or pack‑year calculations) or how to treat borderline causal links between service exposures and listed factors will fall to be resolved in administrative determinations and, if contested, in merits or judicial review proceedings under the VEA/MRCA or general administrative law. Those outcomes are not summarised in the instrument.

Where litigation or review is relevant for practice. Advisers should be aware that SoPs are used in administrative decisions which can be subject to review. Challenges commonly centre on whether the facts meet the SoP’s thresholds, whether a listed factor is sufficiently linked to service per s 10(1), or whether cross‑references to other SoPs should have been applied under s 11. The instrument itself, however, contains no record of such challenges or their outcomes.

No cases named. The instrument does not name any cases, and the Schedule does not reference judicial interpretations. Under the developer instructions you provided, I must not invent case names or litigation outcomes that are not present in the source. Therefore this section is limited to stating that the instrument contains no litigation history and that any relevant case law should be sought in external sources (tribunal decisions, Federal Court judgments, or Veterans’ review tribunal decisions) rather than being inferred from the instrument.

Recommended practitioner action in the absence of instrument‑level precedent. Because the SoP does not itself supply interpretative case law, practitioners handling contested matters should:

• check administrative decisions and tribunal determinations that consider this SoP or any predecessor SoPs (for example the 2010 instrument) to identify established interpretive approaches; and
• where necessary, prepare to argue evidential standards and the application of Schedule definitions in merits or judicial review environments, using clinical literature, service records and expert opinion to bridge gaps not resolved by the instrument.

In short, the instrument contains no litigation history; practitioners must consult external legal records and tribunal decisions when preparing reliance or challenges based on this SoP.

This instrument contains numerous precise thresholds, definitions and relational limits that can produce sharp evidentiary or interpretive issues in claims. Practitioners should treat the listed items as legal triggers with strict temporal and quantitative requirements. The following points are practical “gotchas” that recur in claims assessment.

Single‑factor sufficiency and the “reasonable hypothesis” threshold. The SoP requires only that at least one factor in s 9 exist to raise a reasonable hypothesis connecting sinusitis or death from sinusitis to relevant service. That means a single qualifying exposure documented in the required terms can be decisive at the reasonable hypothesis stage. However, the factor must be related to relevant service under s 10(1). The interplay between single‑factor sufficiency and the service nexus is often the locus of dispute: a claimant may prove a factor existed in civilian life but not its relationship to relevant service.

Timing windows are strict. Several factors contain tight temporal windows. Inhalation of drugs or irritant substances requires acute symptoms within 48 hours of the inhalation and scarring or erosion of mucosa (s 9(8) and s 9(18)). Inhalation of airborne dusts/smoke/fumes/vapours similarly is limited to within 48 hours of clinical onset/worsening (s 9(9) and s 9(19)). Second‑hand smoke exposure requires at least 1,000 hours of exposure with the first exposure at least one year prior and the last exposure within three months before onset/worsening (s 9(7) and s 9(17)). Smoking cessation windows limit causation to within three months of cessation for onset/worsening if smoking has ceased (s 9(6)(b) and s 9(16)(b)). These windows are precise: failure to demonstrate the required timing can be fatal to the reasonable hypothesis at the medical causation step.

Quantification burdens: 1,000 hours and pack‑year calculation. The Schedule defines pack‑year strictly (one pack‑year = 20 tailor‑made cigarettes per day for one year = 7,300 cigarettes = 7.3 kg tobacco). The second‑hand smoke threshold of 1,000 hours (s 9(7)/(17) and Schedule definition) and the pack‑year calculation are quantifiable metrics that can be difficult to evidence post hoc. Claimants often lack contemporaneous logs recording hours of exposure in enclosed spaces. The SoP places the burden on evidence that the metric is met; corroborating testimony, unit logs, workplace records, or contemporaneous medical notes will be key.

Differences between onset and worsening factors and the service relationship rule. Subsections 9(11) to 9(22) apply only to material contribution to or aggravation of sinusitis where the person’s sinusitis was suffered or contracted before or during (but did not arise out of) relevant service (s 10(2)). That creates a legal distinction: if sinusitis arose out of service in the first instance, the worsening factors in 9(11)-(22) do not apply in the same way to material contribution/aggravation analysis. Practitioners must determine whether the sinusitis predates service or arose out of service to know which factors and legal tests apply.

Cross‑reference to other SoPs. Section 11 requires application of any other SoP where a factor in s 9 refers to an injury or disease that has its own SoP. That can complicate causation arguments: a factor listed here may trigger requirements and definitions under a different SoP, potentially altering evidentiary standards. Practitioners need to identify and obtain the relevant SoP(s) and apply them in series.

Schedule definitions that materially alter meaning. The Schedule’s definitions narrow or expand the operation of factors. For example, “impaired drainage of the sinus” includes specific anatomical deformities, soft tissue abnormalities and foreign bodies (Schedule). “Being exposed to second‑hand smoke” is defined narrowly as inhalation in an enclosed space. “Immunocompromised state as specified” is limited to listed conditions and circumstances. These definitions are binding for SoP purposes and can produce unexpected outcomes if evidence is framed at a higher, less precise level.

Listed drugs and substances,examples that practitioners must accept as nominal. The SoP provides illustrative lists for inhaled drugs and irritant substances and for nonselective NSAIDs (s 9(8)/(18) and s 9(21)). Notably, the instrument includes paracetamol within its list of nonselective (COX‑1 and COX‑2 inhibitors) nonsteroidal anti‑inflammatory class of drugs (s 9(21) note). Practitioners should apply the instrument’s lists as written; if the clinical evidence relies on drugs not enumerated or on alternative classification arguments, those matters must be addressed explicitly in medical opinion.

Death linkage via terminal events. For death claims, s 7(5) expands “sinusitis” to include death from a terminal event or condition that was contributed to by the person’s sinusitis. The Schedule defines “terminal event” as a proximate or ultimate cause of death including pneumonia, respiratory failure, cardiac arrest, circulatory failure and cessation of brain function. Practitioners must therefore be prepared to show how underlying sinusitis contributed to one of these terminal events; causation for death‑based claims may require more extensive medical linkage than for non‑fatal sinusitis claims.

Absence of transitional provisions. The instrument repeals the 2010 SoP without setting out transitional rules in the supplied text (s 4). Practitioners should confirm which SoP applies to any claim depending on timing of the claim and decision, and whether any administrative practice has been published regarding transitional application.

Proof of inability to obtain appropriate clinical management. Subsection 9(22) lists inability to obtain appropriate clinical management for sinusitis as a factor for clinical worsening. That factor may be challenging to substantiate: documentary proof of lack of access, systemic barriers during service, or contemporaneous evidence of failed referrals will be required.

In short, the SoP’s prescriptive metrics and definitional precision create evidentiary traps where claimants lack contemporaneous or sufficiently granular documentation. Practitioners should plan evidence collection carefully and address the Schedule definitions and timing requirements head‑on.

Compliance in the context of this SoP means producing and assembling evidence so that a decision‑maker can properly apply the instrument’s criteria and find that a reasonable hypothesis has been raised connecting sinusitis (or death from sinusitis) to relevant service. Compliance duties fall principally on claimants, treating clinicians, and advisers who prepare or manage claims; decision‑makers must apply the SoP’s text and Schedule definitions faithfully.

For claimants and representatives

1. Identify the precise legal test and relevant SoP. Confirm that the claim is one to which s 120A VEA or s 338 MRCA applies (s 5). Obtain and read the full SoP, paying careful attention to s 9 (factors), s 10 (relationship to service), s 11 (cross‑references), and the Schedule definitions.

2. Map the claim to the SoP factors. Determine which s 9 factor(s) are most likely to be evidenced in your client’s circumstances (for example, impaired drainage, respiratory tract infection, immunocompromised state, therapeutic radiation, smoking, second‑hand smoke exposure, inhalation events, specified dental conditions for maxillary sinus). If the claim concerns clinical worsening rather than onset, check whether the limitation in s 10(2) applies.

3. Collect contemporaneous clinical records. Secure GP and specialist notes that document clinical onset and/or worsening dates, objective signs (imaging, endoscopy reports, mucosal scarring/erosion where relevant), laboratory or microbiological results for respiratory infections, and allergy or asthma records for “specified medical condition” claims. For impaired drainage, obtain ENT or surgical records that document anatomical deformities, polyps, scarring, foreign bodies or other listed causes (Schedule).

4. Quantify exposures precisely. For smoking, obtain documentation or credible affidavit evidence demonstrating the pack‑year calculation using the Schedule’s definition (one pack‑year = 20 tailor‑made cigarettes/day for one year = 7,300 cigarettes). For second‑hand smoke, gather contemporaneous evidence (service logs, workplace or barracks records, witness affidavits) showing hours in enclosed spaces with smokers and dates to satisfy the 1,000‑hour and timing requirements (s 9(7)/(17)). For inhalation events, obtain incident reports, unit logs or medical notes that mark the inhalation event and the onset of acute nasal symptoms within 48 hours as required by s 9(8)/(18).

5. Document service nexus. Compile service records and any exposure reports that link the relevant factor to the period or location of relevant service so as to meet s 10(1). For exposures occurring in service environments (for example, fires, dust, fuel fumes), obtain unit reports, after‑action reports, or contemporaneous medical treatment notes.

6. For dental‑related maxillary sinusitis, collect dental records, imaging, operative notes and any recorded oro‑antral fistula or periapical abscess evidence that matches the Schedule’s “specified dental condition” list (s 9(10)/(20) and Schedule).

7. For death claims, obtain the death certificate, autopsy report where available, and medical opinions that explain how sinusitis contributed to a listed “terminal event” (Schedule), with an explanation of proximate causation.

8. Where a factor invokes another disease covered by another SoP, obtain and apply that other SoP. Section 11 requires using the other SoP as in force, so collect those documents and any supporting medical literature.

For treating clinicians and medical experts

1. Structure medical reports against SoP elements. Address whether and when the patient experienced clinical onset or clinical worsening, document objective findings and link these to the SoP’s enumerated factors and the Schedule definitions. When addressing inhalation/injury timelines, explicitly state whether acute nasal symptoms occurred within 48 hours and whether scarring/erosion is present.

2. Quantify smoking and exposure histories. Use the Schedule’s pack‑year calculation when reporting smoking history. Where second‑hand smoke exposure is alleged, provide a reasoned estimation of enclosed exposure hours and any supporting evidence or methodology for that estimate.

3. Explain causal linkage to relevant service. Where possible, tie clinical findings and exposure histories to service records or known exposures during the service period. If a factor is a consequence of treatment (for example, therapeutic radiation where sinuses were in the radiation field), specify the timing and fields treated (s 9(5)/(15)).

4. Anticipate cross‑SoP issues. If the claimed factor relates to a condition with its own SoP, note that and provide clinical findings that satisfy both SoPs where practicable.

For decision‑makers and case officers

1. Apply the SoP as written. Evaluate whether at least one s 9 factor is present on the evidence and whether that factor is related to relevant service (s 10(1)). Use the Schedule for definitional clarity on terms such as pack‑year, impaired drainage, immunocompromised state and being exposed to second‑hand smoke.

2. Distinguish onset vs worsening and apply s 10(2). Determine whether the claim concerns the clinical onset of sinusitis or clinical worsening of pre‑existing sinusitis, and apply subsections 9(11)-9(22) only where the pre‑existing sinusitis arose before or during but did not arise out of relevant service.

3. Seek targeted medical evidence where necessary. When evidence is insufficient on a particular factor (for example, lack of documentation of mucosal scarring or absence of quantifiable second‑hand smoke hours), obtain further clinical reports or request additional examinations rather than making assumptions.

4. Apply other SoPs where referenced. If a factor points to an injury/disease covered by another SoP, obtain and apply that SoP’s terms per s 11.

5. Document clearly. Record in decision documents the specific s 9 factor relied upon, the Schedule definitions applied, and the factual basis for any finding that the factor is related to relevant service.

Practical evidence checklist

• Clinical notes with dates of onset/worsening, objective findings (imaging, endoscopy), and treatment records.
• ENT/surgical reports documenting anatomical causes of impaired drainage where applicable.
• Dental records, radiographs and operative notes for maxillary sinus cases.
• Smoking history quantified per pack‑year definition in the Schedule.
• Corroborated statements or logs for second‑hand smoke exposure hours in enclosed spaces.
• Incident reports or medical notes documenting inhalation events and the 48‑hour symptom onset window.
• Oncology/radiation records showing fields including nasal cavity/paranasal sinuses.
• Records documenting immunosuppressive therapy, malignancy, HIV status, chronic renal failure, transplants or severe malnutrition if claiming immunocompromised state as specified.
• Death certificates, autopsy reports and medico‑legal opinions addressing contribution of sinusitis to a terminal event for mortality claims.

In short, compliance requires aligning evidence to the SoP’s specific factors, timing windows and Schedule definitions, and demonstrating the nexus to relevant service per s 10. Practitioners should plan evidence collection with the SoP criteria in mind and use targeted medical opinion to bridge any gaps in documentary proof.